Intero Biosystems
Miniature human organs for predictive preclinical drug testing
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Intero Biosystems builds complex iPSC-derived human organoids, miniature organs that let pharma companies test drug safety and efficacy on human biology before clinical trials, aiming to identify better medications and cut clinical trial costs. Its first model, GastroScreen, is a human miniature intestine. It was selected for the TechCrunch Disrupt 2026 Startup Battlefield Top 20.
- Website
- interobiosystems.com
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- GastroScreen — iPSC-derived human miniature intestine for preclinical testing · Service